Ashland to increase production capacity for Benecel cellulose ethers by more than 50% by 2023 at its facility in Doel, Belgium; Benecel supports demand for products sold to pharmaceuticals, nutrition and performance specialty applications

Sample article from our Bioeconomy

WILMINGTON, Delaware , January 13, 2022 (press release) –

Supporting customers’ growth is cornerstone of business strategy

Ashland has begun to significantly increase production capacity for Benecel™ cellulose ethers at its facility in Doel, Belgium. When completed in 2023, capacity will be increased by more than 50 percent and supports the growing demand for products sold to pharmaceuticals, nutrition and performance specialty applications.

“This investment underscores our commitment to our customers, and it is a critical element of our growth strategy,” said Ashok Kalyana, senior vice president and general manager, life sciences, Ashland. “We have recently launched new controlled release grades of Benecel ™ for the pharmaceutical market, and we are seeing rapid growth of Benecel™ as a binder for plant-based proteins.”

High-purity Benecel™ cellulose ethers such as methylcellulose (MC) and methyhydroxyethylcellulose (HPMC), are used in a variety of pharmaceutical, nutrition, and personal care applications. In addition, this expansion will add capacity for some other specialty grades used in high-end industrial markets.

About Ashland

Ashland (NYSE: ASH) is a global, consumer market-focused additives and specialty ingredients company that is responsibly solving for a better world. Through science and a conscious and proactive mindset for sustainability, we serve customers in pharmaceutical, personal care, architectural coatings, construction, energy, food, beverage, and nutraceuticals. At Ashland, we are approximately 3,800* passionate, tenacious solvers who thrive on developing practical, innovative, and elegant solutions to complex problems for customers in more than 100 countries. Visit and to learn more.

* Reflects employee base following the planned sale in 2022 of performance adhesives.

™ Trademark, Ashland or its subsidiaries, registered in various countries.


Media Relations
Nina Servino


* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Chelsey Quick
Chelsey Quick
- VP Client Success -

We offer built-to-order bioeconomy coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.